Multiple epitope fusion protein

Details Multiple epitope fusion protein Multiple epitope fusion protein

2006-06-06

2006-06-06

Parkin, J. S. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C435S007100, C424S228100

Reexamination Certificate

active

07056658

ABSTRACT:
Multiple epitope fusion proteins and immunoassays using the same are disclosed. The multiple epitope fusion proteins are encompassed by the general structural formula (A)x−(B)y−C2which represents a linear amino acid sequence, wherein B is an amino acid sequence of an epitope or cluster of epitopes and each B contains at least five and not more than 1,000 amino acids, y is an integer of 2 or more, A and C are each independently an amino acid sequence of an epitope or cluster of epitopes not adjacent to B in nature and x and z are each independently an integer of 0 or more wherein at least one of x and z is 1 or more.

REFERENCES:
patent: 4403036 (1983-09-01), Hartley et al.
patent: 4977079 (1990-12-01), Nuzzolo et al.
patent: 5061619 (1991-10-01), Wilson et al.
patent: 5218099 (1993-06-01), Reyes et al.
patent: 5223400 (1993-06-01), Ling et al.
patent: 5229491 (1993-07-01), Habets et al.
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5582968 (1996-12-01), Wang et al.
patent: 5639594 (1997-06-01), Wang et al.
patent: 2 294 047 (1996-04-01), None
patent: 8-24045 (1997-10-01), None
patent: 9-278794 (1997-10-01), None
patent: 92/08734 (1992-05-01), None
patent: 93/00365 (1993-01-01), None
patent: 93/08280 (1993-04-01), None
patent: 94/01778 (1994-01-01), None
patent: 94/18234 (1994-08-01), None
patent: 94/27153 (1994-11-01), None
patent: 95/03825 (1995-02-01), None
patent: 95/33053 (1995-12-01), None
patent: 96/04301 (1996-02-01), None
Chien et al., “Use of Recombinant HCV Antigen in the Serodiagnosis of Hepatitis C Virus Infection: Significant Improvement in HCV Antibody Detection as Compared with the First Generation HCV C100-3 ELISA and the Synthetic Peptide EIA Test”J. Gastroentrerology and Hepatology 8:S33-S-39, 1993.
Chien et al., “Diagnosis of Hepatitis C Virus (HCV) Infection Using an Immunodominant Chimeric Polyprotein to Capture Circulating Antibodies: Reevaluation of the Role of HCV in Liver Disease”Proc. Natl. Acad. Sci. (USA) 89:10011-10015, 1992.
Chien et al., “Distinct Subtypes of Hepatitis C Virus Defined by Antibodies Directed to the Putative Core, NS4, and NS5 Region Polypeptides”Viral Hepatitis and Liver Disease320-324, 1994.
Ching et al.,“Interaction of Immune Sera with Synthetic Peptides Corresponding to the Structural Protein Region of Hepatitis C Virus”Proc. Natl. Acad. Sci. (USA) 89:3190-3194, 1992.
Sallberg et al., “Immunodominant Regions Within the Hepatitis C Virus Core and Putative Matrix Proteins”J. Clin. Microbiol. 30(8):1989-1994, 1992.
Simmonds et al.,J. Clin. Microbiol. 31:1493-1503, 1993.
Van der Poel et al., “Confirmation of Hepatitis C Virus Infection by New Four-Antigen Recombinant Immunoblot Assay”Lancet 337:317-319, 1991.
Smythe et al., “Production of Linear Polymers of HIV gp120-binding Domains”Protein Eng. 7(2):145-147, Feb., 1994.
Chatterjee et al., “Fine Specificity of Immune Responses to Epitopic Sequences in Synthetic Peptides Containing B and T Epitopes From the Conserved Plasmodium Flaciparum Blood-Stage Antigens”Vaccine 13(15):1474-1481, 1995.
Van der Ploeg et al., “Immunological Properties of Multiple Repeats of a Linear Epitope of Herpes Simplex Virus Type 1 Glycoprotein D”J. Immunol. Methods 124:211-217, 1989.
Brown et al., “Improved Diagnosis of Chronic Hepatitis C Virus Infection by Detection of Antibody to Multiple Epitopes: Confirmation by Antibody to Syntheitic Oligopeptides”J. Medical Virology 38(3):167-171, Nov., 1992.
Pujol et al., “Characterization of the Antibody Reactivity to Synthetic Peptides from Different Parts of the Heptatitis C Virus Genome”Viral Immunology 9(2):89-96, 1996.
Chen et al., “The Structural Influence of Individual Residues Located within Peptide Antigen Depends Upon Their Sequence Context”Molecular Immunology 31(14):1069-1075, Oct., 1994.
Londono et al., “Secondary Structure and Immunogenicity of Hybrid Synthetic Peptides Derived from Two Plasmodium Falciparum Pre-Erythrocytic Antigens”J. Immunology 145(5):1557-1563, Sep., 1990.
Yagi et al., “An Epitope Chimeric Antigen for the Hepatitis C Virus Serological Screening Test”Biol. Pharm. Bull. 19(10):1254-1260, 1996.
Ebeling et al.,Lancet 337:912-913, 1991.
Kotwal et al., “Detection of Acute Hepatitis C Virus Infection by ELISA Using a Synthetic Peptide Comprising a Structural Epitope”Proc. Natl. Acad. Sci. (USA) 89:4486-4489, 1992.
Kuo et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis”Science 244:362-364, 1989.
Machida et al., “Two Distinct Subtypes of Hepatitis C Virus Defined by Antibodies Directed to the Putative Core Protein”Hepatology 16:886-891, 1992.
Nasoff et al., “Identification of an Immunodominant Epitope Within the Capsid Protein of Hepatitis C Virus”Proc. Natl. Acad. Sci. (USA) 88:5462-5466, 1991.
Choo et al., “Genetic Organization and Diversity of the Hepatitis C Virus”Proc. Natl. Acad. Sci. (USA) 88:2451-2455, 1991.
Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Heaptitis Genome”Science 244:359-362, 1989.

Affiliated with

Also associated with

Rating

Multiple epitope fusion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiple epitope fusion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple epitope fusion protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3645985